University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Catherine C. Park, MD

Catherine C. Park, MD

Professor and Chair, Department of Radiation Oncology, UCSF

Cancer Center Program Memberships

Breast Oncology


University of California, Berkeley, CA, B.A., 1989, History of Art
UCLA School of Medicine, Los Angeles, CA, M.D., 1995, Medicine
Beth Israel Hospital, Harvard Medical School, Boston, MA, 1996, Internship, Internal Medicine
Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA, 2000, Residency, Radiation Oncology

Professional Experience

  • 1998-1999
    Research Associate, Lawrence Berkeley National Laboratory, Berkeley, CA
  • 2000-2006
    Visiting Scientist, Lawrence Berkeley National Laboratory, Berkeley, CA
  • 2006-present
    Faculty Biologist, Lawrence Berkeley National Laboratory, Berkeley, CA
  • 2000-2008
    Assistant Professor, Department of Radiation Oncology, UCSF
  • 2008-2014
    Associate Professor, Department of Radiation Oncology, UCSF
  • 2008 - 2014    
    Faculty Biologist,    Division of Life Sciences, Lawrence Berkeley National Laboratory, Berkeley, CA   
  • 2013-present
    Vice Chair, Faculty Mentoring, Mentoring Facilitator, Department of Radiation Oncology, UCSF
  • 2014-present
    Interim Chair and Professor, Department of Radiation Oncology, UCSF

Honors & Awards

  • 1994
    Alpha Omega Alpha
  • 1995
    AMWA Janet M. Glascow Memorial Achievement Citation
  • 1995
    C. Donald O'Malley Prize in the History of Medicine
  • 1995
    Dean's Scholar, Thesis Program UCLA School of Medicine
  • 1995
    Upjohn Achievement Award
  • 2002
    Travel Award, Junior Investigator, International Society for Differentiation, Lyon, France
  • 2002
    Invited Lecturer, European Society for Therapeutic Radiation Oncology, Prague, CZ
  • 2003
    Junior Investigator Award, European Society for Therapeutic Radiation Oncology
  • 2003
    Basic Science Junior Investigator Award, American Society for Therapeutic Radiation Oncology
  • 2005
    Association of American Medical Colleges Early Career Faculty Women's Professional Development Seminar, Santa Fe, NM
  • 2012
    T1 Catalyst AwardUniversity of California, San Francisco
  • 2012
    CORO Leadership WorkshopUCSF School of Medicine
  • 2013
    First Annual Sullivan Lectureship, Berkeley, CALawrence Berkeley National Laboratory
  • 2014
    UCSF Clinical and Translational Science Institute Mentoring Development ProgramUCSF School of Medicine

Selected Publications

  1. Johnson J, Esserman L, Ewing C, Alvarado M, Park C, Fowble B. Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome. Ann Surg Oncol. 2016 Mar; 23(3):715-21.
    View on PubMed
  2. Lin CH, Pelissier FA, Zhang H, Lakins J, Weaver VM, Park C, LaBarge MA. Microenvironment rigidity modulates responses to the HER2 receptor tyrosine kinase inhibitor lapatinib via YAP and TAZ transcription factors. Mol Biol Cell. 2015 Nov 5; 26(22):3946-53.
    View on PubMed
  3. Fowble B, Park C, Wang F, Peled A, Alvarado M, Ewing C, Esserman L, Foster R, Sbitany H, Hanlon A. Rates of Reconstruction Failure in Patients Undergoing Immediate Reconstruction With Tissue Expanders and/or Implants and Postmastectomy Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015 Jul 1; 92(3):634-41.
    View on PubMed
  4. Sethi R, Park C, Fowble B. Postmastectomy radiotherapy in patients with breast cancer. Lancet. 2014 Nov 22; 384(9957):1845.
    View on PubMed
  5. Alvarado MD, Conolly J, Park C, Sakata T, Mohan AJ, Harrison BL, Hayes M, Esserman LJ, Ozanne EM. Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery. Breast Cancer Res Treat. 2014 Jan; 143(1):135-40.
    View on PubMed
  6. Descovich M, Fowble B, Bevan A, Schechter N, Park C, Xia P. Comparison between hybrid direct aperture optimized intensity-modulated radiotherapy and forward planning intensity-modulated radiotherapy for whole breast irradiation. Int J Radiat Oncol Biol Phys. 2010 Jan 1; 76(1):91-9.
    View on PubMed
  7. Hattangadi J, Park C, Rembert J, Klifa C, Hwang J, Gibbs J, Hylton N. Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy. AJR Am J Roentgenol. 2008 Jun; 190(6):1630-6.
    View on PubMed
  8. Park CC, Zhang HJ, Yao ES, Park CJ, Bissell MJ. Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts. Cancer Res. 2008 Jun 1; 68(11):4398-405.
    View on PubMed
  9. Park CK, Miller C, Lawrence G. Addison's disease from non-Hodgkin's lymphoma with normal-size adrenal glands. J Clin Oncol. 2007 Jun 1; 25(16):2322-4.
    View on PubMed
  10. Yao ES, Zhang H, Chen YY, Lee B, Chew K, Moore D, Park C. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res. 2007 Jan 15; 67(2):659-64.
    View on PubMed
  11. Coleman J, Park C, Villarreal-Barajas JE, Petti P, Faddegon B. A comparison of Monte Carlo and Fermi-Eyges-Hogstrom estimates of heart and lung dose from breast electron boost treatment. Int J Radiat Oncol Biol Phys. 2005 Feb 1; 61(2):621-8.
    View on PubMed
  12. Park C, Seid P, Morita E, Iwanaga K, Weinberg V, Quivey J, Hwang ES, Esserman LJ, Leong SP. Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment. Breast J. 2005 Jan-Feb; 11(1):29-33.
    View on PubMed

Go to UCSF Profiles, powered by CTSI